Detalhe da pesquisa
1.
A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance.
J Oncol Pharm Pract
; : 10781552241258175, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38813782
2.
Unusual encephalopathy with Wernicke-Korsakoff syndrome-like features due to adjuvant nivolumab for malignant melanoma.
J Oncol Pharm Pract
; 30(2): 408-411, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981786
3.
Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions.
J Oncol Pharm Pract
; 29(4): 917-926, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718515
4.
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma.
J Oncol Pharm Pract
; 29(5): 1255-1258, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597613
5.
Unusual stroke-like symptoms with oxaliplatin use.
J Oncol Pharm Pract
; 29(7): 1766-1769, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37323007
6.
Widespread vitiligo and poliosis following ipilimumab-nivolumab combination therapy.
J Oncol Pharm Pract
; 29(5): 1278-1282, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36785936
7.
Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.
J Oncol Pharm Pract
; 29(5): 1259-1263, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734125
8.
Acquired angioedema late in the course of nivolumab treatment.
J Oncol Pharm Pract
; : 10781552231170555, 2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069828
9.
Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions.
J Oncol Pharm Pract
; : 10781552231178293, 2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246506
10.
Immune checkpoint inhibitor-related adverse events: Real-world experience from a single veterans' affairs medical center.
J Oncol Pharm Pract
; : 10781552231184178, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37350125
11.
Sustained erythrocytosis due to the use of Lenvatinib.
J Oncol Pharm Pract
; 28(2): 475-478, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34665694
12.
Acute gout flare of bilateral first metatarsophalangeal joints due to ibrutinib use in chronic lymphocytic leukemia.
J Oncol Pharm Pract
; 28(2): 442-444, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225525
13.
Cecal volvulus associated with carfilzomib use for al amyloidosis.
J Oncol Pharm Pract
; 28(5): 1230-1233, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089100
14.
Diabetic ketoacidosis as a hallmark of autoimmune diabetes occurring after two cycles of cemiplimab.
J Oncol Pharm Pract
; 28(3): 722-724, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791931
15.
Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia.
J Oncol Pharm Pract
; 28(5): 1218-1221, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060786
16.
Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin.
J Oncol Pharm Pract
; 28(4): 1003-1008, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037777
17.
A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström's macroglobulinemia.
J Oncol Pharm Pract
; 28(8): 1917-1921, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306909
18.
Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm?
J Oncol Pharm Pract
; 27(1): 205-206, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33241730
19.
Bluish-gray fingernail discoloration due to the use of nivolumab.
J Oncol Pharm Pract
; 27(2): 457-459, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32517636
20.
Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.
J Oncol Pharm Pract
; 27(6): 1534-1538, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33292071